Screener
PTC Therapeutics PTCT Royalty — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenues: | ||
| Net product revenue | $225,573 | $153,426 |
| Collaboration and license revenue | 143 | 986,231 |
| Royalty revenue | 46,835 | 36,439 |
| Total revenues | 272,551 | 1,176,096 |
| Operating expenses: | ||
| Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets | 28,028 | 12,862 |
| Amortization of acquired intangible assets | 11,581 | 3,798 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's royalty — revenue?
- PTC Therapeutics (PTCT) reported royalty — revenue of $46.84M in Q1 2026.
- How has PTC Therapeutics's royalty — revenue changed year-over-year?
- PTC Therapeutics's royalty — revenue increased by 28.5% year-over-year, from $36.44M to $46.84M.
- What is the long-term trend for PTC Therapeutics's royalty — revenue?
- Over 4 years (2021 to 2025), PTC Therapeutics's royalty — revenue has grown at a 45.3% compound annual growth rate (CAGR), from $54.72M to $244.23M.
- What does royalty — revenue mean?
- This metric represents the gross revenue recognized from royalty-based licensing agreements for intellectual property, excluding any pass-through taxes collected from customers. It reflects the income generated from the commercial success of products developed by the company but marketed or sold by third-party partners. This figure serves as a key indicator of the company's ability to monetize its research and development pipeline through strategic licensing and partnership models.
Ask your AI about PTC Therapeutics's royalty — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude